These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 32495696)
1. Modulation of rifampicin-induced hepatotoxicity using poly(lactic-co-glycolic acid) nanoparticles: a study on rat and cell culture models. Hetta HF; Ahmed EA; Hemdan AG; El-Deek HE; Abd-Elregal S; Abd Ellah NH Nanomedicine (Lond); 2020 Jun; 15(14):1375-1390. PubMed ID: 32495696 [No Abstract] [Full Text] [Related]
2. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres. Gajendiran M; Divakar S; Raaman N; Balasubramanian S Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139 [TBL] [Abstract][Full Text] [Related]
3. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055 [TBL] [Abstract][Full Text] [Related]
4. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic- Van Hees S; Elbrink K; De Schryver M; Delputte PL; Kiekens F Nanomedicine (Lond); 2020 Nov; 15(27):2671-2688. PubMed ID: 33112210 [No Abstract] [Full Text] [Related]
6. Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis. D'Souza S; Du Plessis SM; Egieyeh S; Bekale RB; Maphasa RE; Irabin AF; Sampson SL; Dube A J Pharm Sci; 2022 Feb; 111(2):469-478. PubMed ID: 34534573 [TBL] [Abstract][Full Text] [Related]
7. Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles. Grune C; Thamm J; Werz O; Fischer D J Pharm Sci; 2021 Feb; 110(2):959-964. PubMed ID: 33275992 [TBL] [Abstract][Full Text] [Related]
8. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages. Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438 [TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain. Patel BK; Parikh RH; Patel N Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405 [TBL] [Abstract][Full Text] [Related]
11. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilize. Chittasupho C; Thongnopkoon T; Kewsuwan P Curr Drug Deliv; 2016; 13(1):95-104. PubMed ID: 26338259 [TBL] [Abstract][Full Text] [Related]
12. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery. Xu W; Wei X; Wei K; Cao X; Zhong S Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077 [TBL] [Abstract][Full Text] [Related]
13. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats. S S; S M; P S L S; S S; S B; V P Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822 [TBL] [Abstract][Full Text] [Related]
15. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid. Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255 [TBL] [Abstract][Full Text] [Related]
16. Cannabidiol-Loaded Poly Lactic-Co-Glycolic Acid Nanoparticles with Improved Bioavailability as a Potential for Osteoarthritis Therapeutic. Jin Z; Zhan Y; Zheng L; Wei Q; Xu S; Qin Z Chembiochem; 2023 May; 24(9):e202200698. PubMed ID: 36793188 [TBL] [Abstract][Full Text] [Related]
17. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin. Samkange T; D'Souza S; Obikeze K; Dube A J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281 [TBL] [Abstract][Full Text] [Related]
19. Exploring the Toxicity, Lung Distribution, and Cellular Uptake of Rifampicin and Ascorbic Acid-Loaded Alginate Nanoparticles as Therapeutic Treatment of Lung Intracellular Infections. Scolari IR; Volpini X; Fanani ML; La Cruz-Thea B; Natali L; Musri MM; Granero GE Mol Pharm; 2021 Mar; 18(3):807-821. PubMed ID: 33356316 [TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective activity of hepatoplus on isonaizid and rifampicin induced hepatotoxicity in rats. Sankar M; Rajkumar J; Devi J Pak J Pharm Sci; 2015 May; 28(3):983-90. PubMed ID: 26004706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]